RxDoctor Payments DataLook up a doctor →

Jennifer Difalco, MD

Family Medicine · Brockton, MANPI 1558636373

Payments from drug & device makers

$9,382in general payments, 2019–2025

Across 500 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$1K
  • Lilly USA, LLC$915
  • Tosoh Bioscience, Inc.$558
  • Novartis$463
  • Novo Nordisk$441
  • plus $5K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)71$1,298
Pfizer67$1,079
Lilly USA, LLC44$915
Tosoh Bioscience, Inc.1$558
Novartis39$463
Novo Nordisk23$441
Merck20$354
Amgen18$315
Biohaven Pharmaceuticals, Inc.14$270
Antares Pharma, Inc.13$244
AstraZeneca(2 entities)10$224
Eisai Inc.14$197
Exact Sciences8$189
Esperion Therapeutics, Inc.12$185
Shield Therapeutics Inc9$178
GSK9$167
Amarin Pharma, Inc.8$150
Kowa Pharmaceuticals America, Inc.9$150
Boehringer Ingelheim7$144
Abbott9$135
Johnson & Johnson8$131
Sanofi Pasteur Inc.6$119
Therapeuticsmd, Inc.7$110
E.r. Squibb & Sons, L.L.C.5$91
Idorsia Pharmaceuticals US Inc5$83
Mayne Pharma Commercial LLC4$82
Axsome Therapeutics, Inc.4$79
Takeda Pharmaceuticals U.S.A., Inc.5$75
Astellas Pharma US Inc3$68
Vanda Pharmaceuticals Inc.3$68
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$63
Teva Pharmaceuticals USA, Inc.4$61
Medicines3601$50
Amneal Pharmaceuticals LLC2$48
IBSA Pharma Inc.3$46
Edwards Lifesciences1$44
Acerus Pharmaceuticals Corporation3$44
Tolmar, Inc.3$43
Seqirus USA Inc2$41
Hologic Sales And Service, LLC2$40
Otsuka America Pharmaceutical, Inc.2$38
Lucid Diagnostics Inc.2$29
Biohaven Pharmaceutical Holding Company Ltd.2$29
ANI Pharmaceuticals, Inc.1$29
Scilex Pharmaceuticals Inc.2$26
Hikma Pharmaceuticals USA2$26
Phathom Pharmaceuticals, Inc.1$21
Halozyme Inc1$21
Tersera Therapeutics LLC1$20
Sanofi-aventis U.S. LLC1$18
Paratek Pharmaceuticals, Inc.1$18
Endo Pharmaceuticals Inc.1$16
Boston Scientific1$16
Avanir Pharmaceuticals, Inc.1$14
Xeris Pharmaceuticals, Inc.1$13
Genentech USA, Inc.1$12

How this compares

$9,382 in reported general payments places this provider in the 95th percentile of 1,049 family medicine providers in Massachusetts.

See all family medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$51,400
Medicare patients
184
Services billed
1,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Brockton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →